Michael ZürcherApr 20, 20233 minINSIGHTSArticle 71 KVV: The case-by-case approach to reimburse pharmaceuticals – a Swiss specialty
Michael ZürcherMar 8, 20231 minCOMPANY NEWSMeet Swizzard’s CEO Michael Zürcher at BIO-Europe Spring in Basel
Michael ZürcherFeb 15, 20233 minINSIGHTSMarket Access in Switzerland – or how to include medical breakthroughs on the specialties list
Michael ZürcherFeb 1, 20231 minTEAM & PARTNERSBettina Schelbert joins Swizzard as Commercial Director
Michael ZürcherDec 7, 20224 minSWIZZARD CHAMPIONS"Enabling collaboration among member companies is the strength and success of the shqa."
Michael ZürcherNov 2, 20221 minThree reasons why pharmaceutical companies should consider the Swiss healthcare market
Michael ZürcherOct 24, 20221 minTEAM & PARTNERSSwizzard co-founds SMS2DACH network together with MArS (Germany) and Supersonic (Austria)
Michael ZürcherOct 19, 20224 minSWIZZARD CHAMPIONS"Health markets are becoming the drivers of a new economic era."
